Lupin receives FDA’s tentative approval for Siponimod tablets
Siponimod Tablets is indicated for the treatment of relapsing forms of multiple sclerosis
Siponimod Tablets is indicated for the treatment of relapsing forms of multiple sclerosis
Growing patent filings and tier-2 innovators reflect expanding national research base
Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups, supporting a broad range of oral dosing applications
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Sun Pharma to set up Rs. 3,000 crore greenfield formulations facility in MP
The partnership aims to combine TQx’s in vivo therapeutic expertise with Kytopen’s continuous flow transfection technology
The technology is intended to support imaging-based training, protocol optimisation and surgical planning
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
Subscribe To Our Newsletter & Stay Updated